Handelsbanken Fonder’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $720K | Hold |
16,500
| – | – | ﹤0.01% | 1093 |
|
|
2025
Q1 | $452K | Hold |
16,500
| – | – | ﹤0.01% | 1270 |
|
|
2024
Q4 | $664K | Sell |
16,500
-800
| -5% | -$32.2K | ﹤0.01% | 1175 |
|
|
2024
Q3 | $819K | Buy |
17,300
+1,900
| +12% | +$89.9K | ﹤0.01% | 1024 |
|
|
2024
Q2 | $460K | Buy |
+15,400
| New | +$460K | ﹤0.01% | 1194 |
|
|
2023
Q4 | – | Sell |
-10,600
| Closed | -$147K | – | 1579 |
|
|
2023
Q3 | $147K | Hold |
10,600
| – | – | ﹤0.01% | 1514 |
|
|
2023
Q2 | $244K | Sell |
10,600
-5,300
| -33% | -$122K | ﹤0.01% | 1429 |
|
|
2023
Q1 | $471K | Hold |
15,900
| – | – | ﹤0.01% | 1026 |
|
|
2022
Q4 | $397K | Buy |
+15,900
| New | +$397K | ﹤0.01% | 1084 |
|
|
2022
Q2 | – | Sell |
-7,700
| Closed | -$326K | – | 1660 |
|
|
2022
Q1 | $326K | Hold |
7,700
| – | – | ﹤0.01% | 1472 |
|
|
2021
Q4 | $489K | Sell |
7,700
-1,100
| -13% | -$69.9K | ﹤0.01% | 1365 |
|
|
2021
Q3 | $517K | Hold |
8,800
| – | – | ﹤0.01% | 1345 |
|
|
2021
Q2 | $427K | Buy |
+8,800
| New | +$427K | ﹤0.01% | 1489 |
|